Demodicidosis in a child with xantholeukaemia associated with type 1 neurofibromatosis.
Although Demodex follicularum and Demodex brevis are common permanent ectoparasites of human pilosebaceous units, their incidence on children's skin is rare. We report a new case of demodicidosis in a 22-month-old girl undergoing chemotherapy for chronic myelomonocytic leukaemia associated with xanthoma and type 1 neurofibromatosis. The eruption cleared after oral and topical metronidazole therapy. Demodicidosis should be included in the differential diagnosis of facial eruption in immunosuppressed children.
Benessahraoui
Mouna
M
Department of Dermatology, 2 Place Saint Jacques, 25030 Besançon Cedex, France.
Paratte
France
F
Plouvier
Emmanuel
E
Humbert
Philippe
P
Aubin
François
F
D000279:Administration, Cutaneous; D000284:Administration, Oral; D000818:Animals; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003937:Diagnosis, Differential; D005148:Facial Dermatoses / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007223:Infant; D015477:Leukemia, Myelomonocytic, Chronic / Q000150:complications* / Q000188:drug therapy; D008795:Metronidazole / Q000008:administration & dosage / Q000627:therapeutic use; D008924:Mite Infestations / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D008925:Mites / Q000145:classification; D009456:Neurofibromatosis 1 / Q000150:complications* / Q000188:drug therapy
D000890:Anti-Infective Agents; D008795:Metronidazole